NCT03956576View on ClinicalTrials.gov

Apelin as a Potential Treatment for Chronic Kidney Disease

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

February 4, 2020

Primary Completion Date

December 14, 2022

Study Completion Date

December 14, 2022

Conditions
Chronic Kidney DiseasesCardiovascular DiseasesEndothelial Dysfunction
Interventions
OTHER

[Pyr]apelin-13

Peptide \[Pyr\]apelin-13 infusion

Trial Locations (1)

EH4 2XU

Clinical Research Centre, Western General Hospital, Edinburgh

All Listed Sponsors
collaborator

Kidney Cancer UK

OTHER

lead

University of Edinburgh

OTHER

NCT03956576 - Apelin as a Potential Treatment for Chronic Kidney Disease | Biotech Hunter | Biotech Hunter